Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease

• Status: Completed
• Trial end date: 2018-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to assess the long-term safety and efficacy of bixalomer under post-marketed setting.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc

Criteria

Inclusion Criteria:

• Patients with pre-dialysis chronic kidney disease complicated by hyperphosphatemia who used bixalomer for the first time